Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer
Completed · Phase 2
Conditions studied: Breast Cancer
In brief
This is a multicenter phase 2 study designed to evaluate the safety and efficacy of eribulin mesylate in combination with trastuzumab as first line treatment in female subjects with locally recurrent or metastatic human epidermal growth factor receptor (HER2) positive breast cancer.
Key facts
- Study ID
- NCT01269346
- Run by
- Eisai Inc.
- People needed
- 52
- Starts
- 2010-12-01
- Expected to finish
- 2016-05-01
- Last updated by the study team
- 2023-06-22
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- University of Colorado — Denver, Colorado, United States
- Florida Cancer Care — Davie, Florida, United States
- Florida Oncology Associates — Jacksonville, Florida, United States
- Ocala Oncology Center — Ocala, Florida, United States
- Peachtree Hematology Oncology Associates, PC — Atlanta, Georgia, United States
- Northwest Georgia Oncology Centers, P.C. — Marietta, Georgia, United States
- Montgomery Cancer Center — Mount Sterling, Kentucky, United States
- Jackson Oncology Associates, PLLC — Jackson, Mississippi, United States
- Heartland Regional Medical Center — Saint Joseph, Missouri, United States
- Weill Cornell Breast Clinic — New York, New York, United States
- Raleigh Hematology Associates — Raleigh, North Carolina, United States
- Cancer Care of the Cascades — Bend, Oregon, United States
- Medical Oncology Associates of Wyoming Valley, P.C. — Kingston, Pennsylvania, United States
- Charleston Hematology/Oncology — Charleston, South Carolina, United States
- Medical University of South Carolina — Charleston, South Carolina, United States
- C. Michael Jones, MD — Germantown, Tennessee, United States
- Texas Oncology - Beaumont Marnie McFaddin Ward Cancer Center — Beaumont, Texas, United States
- Texas Oncology - Medical City Dallas — Dallas, Texas, United States
- Texas Oncology - El Paso Cancer Treatment Center Grandview — El Paso, Texas, United States
- Texas Oncology - Memorial City — Houston, Texas, United States
- Texas Oncology - McAllen South Second Street — McAllen, Texas, United States
- Cancer Care Centers of South Texas — San Antonio, Texas, United States
- Texas Oncology - Sherman — Sherman, Texas, United States
- Texas Oncology - Sugar Land — Sugar Land, Texas, United States
- Pensisula Cancer Institute — Newport News, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.